Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive Symptoms

NCT06755671 is registered in ClinicalTrials.gov with Shanghai Hutchison Pharmaceuticals Limited as lead sponsor.

NCT NCT06755671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06755671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive Symptoms
Lead sponsor
Shanghai Hutchison Pharmaceuticals Limited
Phase
Observational
Overall status
Recruiting
Start date
April 30, 2025
Completion date
June 30, 2027
Enrollment
4,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bloating, constipation, dyspepsia, functional dyspepsia, indigestion, loss of appetite, reflux acid, upper abdominal pain